FarmavitaR+

...regulatory affairs network

  • Increase font size
  • Default font size
  • Decrease font size
Search
Search Only:

Search Keyword research

Total: 13 results found.

1. Advances in Imaging Biomarkers
(Reports/Market Report)
... provide non-invasive approaches that are translatable from the laboratory to the clinic & allow researchers & clinicians to see in great detail how drugs are behaving in vivo. Small animal imaging ...
2. Evolution Summit 2010
(Events/Events)
... the leadership of a new bold visionary who will bring fundamental innovation to overhauling the research approaches of the past. When gearing up for the future, pharmaceutical and biopharmaceutical companies ...
3. Pricing and Reimbursement Conference Review
(Pricing and Reimbursment/Pricing and Reimbursment)
... for many innovative pharmaceutical solutions (readability testing, intensive research and manufacturing of mAb, etc.). In the UK such approach creates additional administrative burden for healthcare ...
4. New Approaches to Pharma R&D
(Reports/Market Report)
... many companies going bankrupt, this will affect Big Pharma in the longer term, which is increasingly downsizing internal research becoming ever reliant on external sources. Read more...  ...
5. Clinical Trial in India
(Clinical Trilas/Asia)
... clinical trials. Reduced costs combined with easy availability of patients with varied diseases makes developing countries favourite destinations for clinical research outsourcing. The whole 9 pages ...
6. Biosimilars expansion in the USA
(Biosimilars/Biosmimilars)
... only the larger and more established companies with higher brand recognition and marketing budgets will succeed Related research: Biosimilars Series: Forecast Analysis priced $11,400 DMHC2477 Negotiating ...
7. Drug repositioning
(Regulatory Affairs/Other issues)
...  Related research: • New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency priced $5,700 DMHC2521 • Future Pharmaceutical Industry Trends: Long-term opportunities ...
... phases of research. This report will describe these technologies, their place in the drug discovery and development paradigm and their value for improving drug safety. Terminating potential new ...
9. Nanotubes
(Regulatory Affairs/General Gulielines)
... due to their light weight and supreme strength, which is said to be stronger than steel. As the variety of uses for nanotubes increases, researchers continue to do studies and tests related to the ...
10. Online Patient Recruitment
(Reports/Market Report)
... of the clinical research process. Poor perception was seen as the biggest hurdle in patient recruitment. Once the potential volunteers have been targeted, it is important to convert them into participants. ...
11. Postmarketing Clinical Research
(Clinical Trilas/European Union)
The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends Emerging Role of Postmarketing Clinical Research is a report published by Business Insights ...
12. Chinese Pharmaceutical Market Overview
(Reports/Market Report)
... has experienced pronounced and rapid expansion in recent years, driven by the growth of both Chinese and Western manufacturers. Increasingly, there is a shift towards a research-based industry, focused ...
In this section are published professional and research articles related to life sciences. Members of FarmavitaR+ are invited to submit their articles to this section.  ...
Banner

FarmavitaR+ Statistics

Members : 583
Content : 221
Web Links : 5
Content View Hits : 520027

Who's Online

We have 10 guests online

Featured Partners

Regulanet - regulatory affairs consortium

regulanet®: Local representation for Global Regulatory Affairs

Farmavita.Net - pharmaceutical lisensing network

Pharmaceutical Licenesing and technology transfer

 

 

 

 

 


Active Groups